For research use only. Not for therapeutic Use.
Pargyline hydrochloride(Cat No.:I003079)is a monoamine oxidase inhibitor (MAOI) used primarily in the treatment of hypertension and certain mood disorders. By inhibiting the enzyme monoamine oxidase (MAO), which breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine, pargyline helps increase the availability of these chemicals in the brain, improving mood and blood pressure regulation. It has also been investigated for its neuroprotective properties, particularly in neurodegenerative diseases. However, due to potential side effects and dietary restrictions associated with MAOIs, its use is typically reserved for cases where other treatments are ineffective.
Catalog Number | I003079 |
CAS Number | 306-07-0 |
Synonyms | N-methyl-N-2-propynyl-benzenemethanamine, monohydrochloride |
Molecular Formula | C₁₁H₁₃N.HCl |
Purity | ≥95% |
Target | Monoamine Oxidase |
Solubility | DMSO:≥ 32 mg/mL |
Storage | Store at -20°C |
IUPAC Name | N-benzyl-N-methylprop-2-yn-1-amine;hydrochloride |
InChI | InChI=1S/C11H13N.ClH/c1-3-9-12(2)10-11-7-5-4-6-8-11;/h1,4-8H,9-10H2,2H3;1H |
InChIKey | BCXCABRDBBWWGY-UHFFFAOYSA-N |
SMILES | CN(CC#C)CC1=CC=CC=C1.Cl |